The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Gene Transfer and Hepatic Overexpression of the HDL Receptor SR-BI Reduces Atherosclerosis in the Cholesterol-Fed LDL Receptor–Deficient Mouse
Open accessAbstract
Abstract —HDL cholesterol levels in humans are inversely correlated with the risk of atherosclerosis. The class B scavenger receptor type I (SR-BI) is the first molecularly well-defined HDL receptor, and hepatic overexpression of SR-BI in normal mice has been shown to result in decreased plasma HDL cholesterol levels. To determine whether SR-BI overexpression is proatherogenic or is protective against atherosclerosis, LDL receptor–deficient mice were placed on a high-fat/high-cholesterol diet for 2 or 12 weeks to induce atherosclerotic lesions of different stages and then were injected with a recombinant adenovirus encoding murine SR-BI. Transient hepatic overexpression of SR-BI in mice with both early and advanced lesions significantly decreased atherosclerosis. SR-BI expression was associated with markedly decreased HDL cholesterol and either unchanged or only modestly reduced non-HDL cholesterol levels; in all experiments, the mean HDL cholesterol levels were significantly correlated with atherosclerotic lesion size. These data suggest that interventions that promote HDL cholesterol transport and lower plasma HDL cholesterol levels can suppress atherosclerosis, even when initiated after significant lesion development. Thus, stimulation of hepatic SR-BI activity may provide a novel target for therapeutic intervention in atherosclerotic cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Self-citationHigh-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., & Krieger, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12610 · Cited by 860
Self-citationExpression cloning of SR-BI, a CD36-related class B scavenger receptor.
Acton, S. L., Scherer, P. E., Lodish, H. F., & Krieger, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31921-x · Cited by 821
Self-citationIshibashi, S., Goldstein, J. L., Brown, M. S., Herz, J., & Burns, D. K. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117179 · Cited by 728
Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
Kozarsky, K. F., Donahee, M. H., Rigotti, A., Iqbal, S. N., Edelman, E. R., & Krieger, M. (1997) · Nature · doi:10.1038/387414a0 · Cited by 699
Self-citationPlasma high density lipoproteins. Metabolism and relationship to atherogenesis.
Tall, A. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114722 · Cited by 652
Zhong, S., Sharp, D. S., Grove, J. S., Bruce, C., Yano, K., Curb, J. D., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118751 · Cited by 583
Plump, A. S., Scott, C. J., & Breslow, J. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9607 · Cited by 568
Mouse Models of Atherosclerosis
Breslow, J. L. (1996) · Science · doi:10.1126/science.272.5262.685 · Cited by 549
Landschulz, K. T., Pathak, R. K., Rigotti, A., Krieger, M., & Hobbs, H. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118883 · Cited by 536
Self-citationKrieger, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.523 · Cited by 519
Self-citationTangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Glass, C., Pittman, R. C., Weinstein, D. B., & Steinberg, D. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5435 · Cited by 491
Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
Pászty, C., Maeda, N., Verstuyft, J., & Rubin, E. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117412 · Cited by 374
Murao, K., Terpstra, V., Green, S. R., Kondratenko, N., Steinberg, D., & Quehenberger, O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17551 · Cited by 322
Arai, T., Wang, N., Bezouevski, M., Welch, C., & Tall, A. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2366 · Cited by 312
Varban, M. L., Rinninger, F., Wang, N., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Gosselin, M. L., Dixon, K. L., Deeds, J. D., Acton, S. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4619 · Cited by 303
Calvo, D., & Vega, M. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46716-0 · Cited by 298
Wang, N., Arai, T., Ji, Y., Rinninger, F., & Tall, A. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32920 · Cited by 275
Hayek, T., Masucci-Magoulas, L., Jiang, X., Walsh, A., Rubin, E., Breslow, J. L., & Tall, A. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118255 · Cited by 265
Structure and Localization of the Human Gene Encoding SR-BI/CLA-1
Cao, G., Garcia, C. K., Wyne, K. L., Schultz, R. A., Parker, K. L., & Hobbs, H. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33068 · Cited by 261
Calvo, D., Gómez-Coronado, D., Lasunción, M. A., & Vega, M. A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2341 · Cited by 241
Reichl, D., & Miller, N. E. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.6.785 · Cited by 237
Ueda, Y., Royer, L., Gong, E., Zhang, J., Cooper, P. N., Francone, O., & Rubin, E. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7165 · Cited by 226
Bérard, A. M., Föger, B., Remaley, A., Shamburek, R., Vaisman, B. L., Talley, G., Paigen, B., Hoyt, R. F., Marcovina, S., Brewer, H. B., et al. (1997) · Nature Medicine · doi:10.1038/nm0797-744 · Cited by 209
Ye, X., Robinson, M. B., Batshaw, M. L., Furth, E. E., Smith, I. R. L., & Wilson, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3639 · Cited by 161
The “best” of cholesterols, the “worst” of cholesterols: A tale of two receptors
Krieger, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4077 · Cited by 154
Self-citationPlasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis
Xiao, Q., Danton, M. J. S., Witte, D. P., Kowala, M. C., Valentine, M. T., Bugge, T. H., & Degen, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10335 · Cited by 130
Voyiaziakis, E., Goldberg, I. J., Plump, A. S., Rubin, E. M., Breslow, J. L., & Huang, L. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33893-1 · Cited by 111
A Docking Receptor for HDL Cholesterol Esters
Steinberg, D. H. (1996) · Science · doi:10.1126/science.271.5248.460 · Cited by 90
Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.
Xiao, Q., Danton, M. J. S., Witte, D. P., Kowala, M. C., Valentine, M. T., & Degen, J. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1461 · Cited by 79
HDL Deficiency in Genetically Engineered Mice Requires Elevated LDL to Accelerate Atherogenesis
Hughes, S. D., Verstuyft, J. G., & Rubin, E. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1725 · Cited by 51
Extravascular circulation of lipoproteins: their role in reverse transport of cholesterol
Reichl, D. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90042-6 · Cited by 29
Tsukamoto, K., Hiester, K. G., Smith, P., Usher, D. C., Glick, J. M., & Rader, D. J. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37161-3 · Cited by 29
Self-citationFrancone, O. L., Fielding, C. J., & Fielding, P. E. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42106-6 · Cited by 27
Cited by
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Scavenger receptors in homeostasis and immunity
Canton, J., Neculai, D., & Grinstein, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3515 · Cited by 838
von Eckardstein, A., Nofer, J.-R., & Assmann, G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 695
Diabetic Dyslipidemia: Causes and Consequences
Goldberg, I. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.965 · Cited by 643
Molecular regulation of HDL metabolism and function: implications for novel therapies
Rader, D. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30163 · Cited by 599
Self-citation
Metadata
- Authors
- Kozarsky, K. F., Donahee, M. H., Glick, J. M., Krieger, M., & Rader, D. J.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2000-03
- Volume
- 20
- Issue
- 3
- Pages
- 721-727
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2169283243
- Cited by
- 337
- References
- 36
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.